Arrowhead’s Annual Pain & Migraine Therapeutics Summit is the US’s premier pain conference covering the field of pain research and therapeutics. Leaders from the pharmaceutical, biotech, device, and medical communities attend this conference to learn about the latest advances in the treatment of various types of pain and to network with colleagues from industry, the nonprofit sector, academia, the medical community, government, and investors.
This conference provides attendees with thoughtful insight from key industry leaders and academic researchers concerning cutting-edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies, and newly marketed products. We will highlight the most important developments in recent years in the field, including the following:
Clinical Trial Design and Endpoints for Pain
Emerging Pain Research from Industry, Academia and Government
CGRP Antagonist Research and Clinical Trial Data
The Latest Diagnostic Imaging Research
NGF antagonist Research and Clinical Trial Data
Emerging Trends and New Animal Model Research
Nociceptive Pain, Neuropathic Pain, Inflammatory Pain, Migraine Pain, Post-Operative Pain, Cancer Pain and Other Types
New Research in Biologic Therapy Development
Non-Opiate Pain Drug Development Trends and Clinical Development Programs
Sodium and Calcium Channel Blocker Research and Clinical Trials